China International Capital Corporation Limited is specialized in providing investment services for businesses, institutions and individuals. The company provides investment banking, securities sales and trading, asset management and private equity investment services.

Employees

14,600

Sector

Investment Banking & Brokerage Services

Calendar

Mar. 29 - Q4 2025 Earnings Release (Projected)

More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.31CNY

Average target price

24.12CNY

Spread / Average Target

+39.32%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Delayed Hong Kong S.E. Other stock markets 03:08:25 2025-11-19 am EST			5-day change	1st Jan Change
18.96 ^HKD	-1.61%		-.--%	+47.89%

Nov. 27	MLOptic Raises 563 Million Yuan in Bonds	MT
Nov. 20	China Stocks Fall as Central Bank Rate Stays Unchanged; Securities Shares See Movement	MT

Capitalization	136B 149B 19.17B 16.48B 15.43B 14.39B 26.57B 1,725B 28.9B 181B 69.71B 815B 71.94B 70.4B 2,979B	P/E ratio 2025 *	11.4x	P/E ratio 2026 *	9.89x
Enterprise value	230B 254B 32.59B 28.02B 26.25B 24.46B 45.18B 2,933B 49.15B 307B 119B 1,385B 122B 120B 5,066B	EV / Sales 2025 *	8.46x	EV / Sales 2026 *	4.04x
Free-Float	50.92%	Yield 2025 *	1.63%	Yield 2026 *	1.84%

Nov. 27	MLOptic Raises 563 Million Yuan in Bonds	MT
Nov. 20	China Stocks Fall as Central Bank Rate Stays Unchanged; Securities Shares See Movement	MT
Nov. 19	China International Capital Plans to Acquire Dongxing, Cinda Securities Through Share Swap	MT
Nov. 19	China's Financial Sector Consolidates Further as CICC Plans Merger With Two Brokerages	DJ
Nov. 19	Biocytogen Pharmaceuticals (Beijing) Launches Shanghai IPO	MT
Nov. 05	Argo Biopharmaceutical Finalizes Banks for Hong Kong Listing	MT
Nov. 04	Guangdong Haid Taps Banks for Planned Hong Kong Listing	MT
Oct. 31	China International Capital Corporation Limited Approves Interim Cash Dividend for 2025, Payable on December 29, 2025	CI
Oct. 31	China International Capital Corporation Limited Announces Board and Committee Changes, Effective October 31, 2025	CI
Oct. 30	China International Capital's Q3 Profit Soars 255%, Revenue Jumps 75%; Shares Down 2%	MT
Oct. 29	China International Capital Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
Oct. 27	Vigonvita Life Sciences Launches HK$598 Million Hong Kong IPO	MT
Oct. 20	Espressif Systems Co., Ltd. announced that it has received CNY 1.7778767 billion in funding from a group of investors	CI

Nov. 04	Guangdong Haid Taps Banks for Planned Hong Kong Listing	MT
22-09-01	UBS Adjusts China International Capital's Price Target to 61 Yuan From 62.60 Yuan, Keeps at Buy	MT
22-07-11	Nomura Adjusts China International Capital's Price Target to HK$26.83 From HK$29.11, Keeps at Buy	MT
21-05-28	CHINA INTERNATIONAL CAPITAL : Nomura Adjusts China International Capital's Price Target to HK$28.68 From HK$28.62, Keeps at Buy	MT
21-02-02	CHINA INTERNATIONAL CAPITAL : Nomura Adjusts China International Capital's Price Target to HK$28.62 From HK$23.69, Keeps at Buy	MT

China International Capital Corporation Limited Stock

Equities

3908

CNE100002359

Investment Banking & Brokerage Services

Valuation: China International Capital Corporation Limited

Chart: China International Capital Corporation Limited

Latest news: China International Capital Corporation Limited

Analysts' recommendations: China International Capital Corporation Limited

Press Releases: China International Capital Corporation Limited

News in other languages: China International Capital Corporation Limited

Quotes and Performance

Course Extremes

Managers and Directors: China International Capital Corporation Limited

ETFs: China International Capital Corporation Limited

Other Investment Banking & Brokerage Services

Financials

Company Profile

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

Sep. 11	HKMC and CICC Sign MoU on Co-operation of Infrastructure Financing and Securitisation	AQ
Jul. 01	Fitch Affirms China International Capital Corporation and Subsidiary at 'BBB+'; Outlook Stable	AQ
24-09-11	Belt and Road Summit Opened Today	AQ
24-07-08	Fitch Affirms China International Capital Corporation and Subsidiary at 'BBB+'; Outlook Stable	AQ
24-01-17	Fitch Assigns Final 'BBB+' to CICC International's Notes from USD MTN Programme	AQ

24-01-23	Los derivados "bolas de nieve" amplifican los riesgos bursátiles en China
23-10-19	Country Garden en risque de défaut, les créanciers veulent entamer des discussions
23-10-19	China impulsa la internacionalización del yuan en el marco de la Iniciativa de la Franja y la Ruta
23-10-19	Los bonistas de la china Country Garden piden diálogo tras el incumplimiento de un pago
23-10-17	Toda la deuda en el extranjero de Country Garden entrará en mora si no efectúa el pago del martes

1 day	-1.61%
1 month	-6.42%
3 months	-7.78%
6 months	+20.46%
Current year	+47.89%

1 month	18.79	20.52
Current year	11.52	24.34
1 year	11.52	24.34
3 years	7.81	24.65
5 years	7.81	25.75
10 years	7.81	25.75

Manager	Title	Age	Since
Yi Cheng Xu DFI	Director of Finance/CFO	51	2024-04-09
Long Cheng CTO	Chief Tech/Sci/R&D Officer	49	2021-02-28
Jia Xing Zhou CMP	Compliance Officer	53	2021-12-27

Director	Title	Age	Since
Peter Nolan BRD	Director/Board Member	76	2020-01-31
Kong-Ping Ng BRD	Director/Board Member	68	2022-06-22
Zheng Fei Lu BRD	Director/Board Member	62	2022-06-22

Name	Weight	AuM	Varia. Jan 1.	Investor
CIMB FTSE CHINA 50 ETF - MYR	0.27%	1 M€	+15.99%	-
LEVERAGE SHARES -3X SHORT CHINA ETP SECURITIES - USD	0.13%	0 M€	0.00%	-

	2025 *	2026 *
Net sales	27.23B 29.98B 3.85B 3.31B 3.1B 2.89B 5.34B 347B 5.81B 36.27B 14.01B 164B 14.45B 14.15B 599B	30.19B 33.24B 4.27B 3.67B 3.44B 3.2B 5.92B 384B 6.44B 40.22B 15.53B 181B 16.03B 15.68B 664B
Net income	8.7B 9.58B 1.23B 1.06B 991M 924M 1.71B 111B 1.86B 11.59B 4.48B 52.31B 4.62B 4.52B 191B	9.42B 10.37B 1.33B 1.15B 1.07B 1B 1.85B 120B 2.01B 12.55B 4.85B 56.63B 5B 4.89B 207B
Net Debt	94.92B 105B 13.43B 11.54B 10.81B 10.08B 18.61B 1,208B 20.25B 126B 48.83B 571B 50.39B 49.32B 2,087B	-13.6B -14.97B -1.92B -1.65B -1.55B -1.44B -2.67B -173B -2.9B -18.11B -6.99B -81.74B -7.22B -7.06B -299B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED	-1.61%	-.--%	+32.03%	+28.46%	19.06B
MORGAN STANLEY	+0.93%	+4.04%	+35.82%	+102.23%	281B
THE GOLDMAN SACHS GROUP, INC.	+2.00%	+3.45%	+42.50%	+137.43%	268B
CITIGROUP INC.	+1.01%	+5.10%	+50.91%	+143.74%	195B
CHARLES SCHWAB	-1.27%	+1.18%	+15.16%	+17.00%	167B
CITIC SECURITIES COMPANY LIMITED	+2.43%	+0.98%	-10.82%	+35.31%	57.21B
RAYMOND JAMES FINANCIAL, INC.	+0.33%	+4.21%	-0.17%	+43.21%	32.08B
LPL FINANCIAL HOLDINGS INC.	+0.50%	+4.20%	+13.26%	+65.29%	29.69B
HUATAI SECURITIES CO., LTD.	+2.78%	+3.32%	+17.02%	+64.16%	26.31B
CSC FINANCIAL CO., LTD.	+4.12%	+7.39%	+13.31%	+85.12%	25.64B
Average	+1.15%	+2.30%	+20.90%	+72.19%	110.02B
Weighted average by Cap.	+1.00%	+3.26%	+31.87%	+96.46%